TRCT
Tower Research Capital (TRC) Portfolio holdings
AUM
$3.71B
1-Year Return
19.93%
This Quarter Return
+9.19%
1 Year Return
+19.93%
3 Year Return
+90.1%
5 Year Return
+158.53%
10 Year Return
+284.02%
AUM
$1.2B
AUM Growth
-$255M
(-17%)
Cap. Flow
-$347M
Cap. Flow
% of AUM
-28.78%
Top 10 Holdings %
Top 10 Hldgs %
51.29%
Holding
4,943
New
707
Increased
1,155
Reduced
1,650
Closed
1,315
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$176M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$164M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$24.4M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$19.8M |
| 5 |
SPDR S&P MidCap 400 ETF Trust
MDY
|
+$15.7M |
Top Sells
| 1 |
Consumers Staples Select Sector SPDR Fund
XLP
|
+$53.4M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$24.1M |
| 3 |
Apple
AAPL
|
+$23.1M |
| 4 |
Visa
V
|
+$22M |
| 5 |
Microsoft
MSFT
|
+$20.1M |
Sector Composition
| 1 | Technology | 2.74% |
| 2 | Financials | 2.53% |
| 3 | Healthcare | 2.3% |
| 4 | Consumer Discretionary | 2.11% |
| 5 | Industrials | 1.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
576
nVent Electric
NVT
$15.4B
| $202K | 0.02% |
7,899
+3,768
| +91% | +$96.4K |
|
|
GAP
577
The Gap, Inc.
GAP
$8.8B
| $201K | 0.02% |
11,359
-3,066
| -21% | -$54.3K |
|
|
PRNB
578
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $201K | 0.02% |
3,674
+2,930
| +394% | +$160K |
|
|
CADE
579
DELISTED
Cadence Bancorporation
CADE
| $201K | 0.02% |
+11,076
| New | +$201K |
|
580
Copart
CPRT
$46.6B
| $200K | 0.02% |
8,788
-3,604
| -29% | -$82K |
|
581
Eli Lilly
LLY
$670B
| $200K | 0.02% |
1,519
-11,276
| -88% | -$1.48M |
|
582
Agios Pharmaceuticals
AGIO
$2.07B
| $199K | 0.02% |
4,171
+3,507
| +528% | +$167K |
|
583
Charles River Laboratories
CRL
$7.74B
| $199K | 0.02% |
1,304
+707
| +118% | +$108K |
|
584
SPDR S&P Regional Banking ETF
KRE
$4.25B
| $199K | 0.02% |
3,413
-42,653
| -93% | -$2.49M |
|
585
Nektar Therapeutics
NKTR
$908M
| $199K | 0.02% |
614
+36
| +6% | +$11.7K |
|
586
Qiagen
QGEN
$10.1B
| $199K | 0.02% |
5,556
+3,913
| +238% | +$140K |
|
587
LiveRamp
RAMP
$1.78B
| $199K | 0.02% |
4,136
+153
| +4% | +$7.36K |
|
588
Sonoco
SON
$4.51B
| $199K | 0.02% |
3,232
+1,656
| +105% | +$102K |
|
|
WRI
589
DELISTED
Weingarten Realty Investors
WRI
| $199K | 0.02% |
6,376
+2,668
| +72% | +$83.3K |
|
590
Amgen
AMGN
$150B
| $198K | 0.02% |
823
-6,956
| -89% | -$1.67M |
|
591
ICU Medical
ICUI
$3.28B
| $198K | 0.02% |
1,057
+971
| +1,129% | +$182K |
|
592
Old National Bancorp
ONB
$8.81B
| $198K | 0.02% |
10,843
+6,591
| +155% | +$120K |
|
593
Core Laboratories
CLB
$598M
| $197K | 0.02% |
5,220
+4,897
| +1,516% | +$185K |
|
594
United Bankshares
UBSI
$5.37B
| $197K | 0.02% |
5,087
+1,801
| +55% | +$69.7K |
|
595
Unilever
UL
$154B
| $197K | 0.02% |
3,453
+1,068
| +45% | +$60.9K |
|
|
CCXI
596
DELISTED
ChemoCentryx, Inc.
CCXI
| $197K | 0.02% |
4,993
+3,548
| +246% | +$140K |
|
597
Vertex Pharmaceuticals
VRTX
$101B
| $196K | 0.02% |
897
-4,736
| -84% | -$1.03M |
|
598
Schwab Fundamental US Large Company Index ETF
FNDX
$19.9B
| $196K | 0.02% |
13,830
-20,646
| -60% | -$293K |
|
599
Moderna
MRNA
$9.78B
| $196K | 0.02% |
10,017
+5,491
| +121% | +$107K |
|
600
La-Z-Boy
LZB
$1.44B
| $195K | 0.02% |
+6,182
| New | +$195K |
|